I'm a biotech executive and scientist with a passion for advancing oncology therapeutics from discovery through clinical development. Over the course of my career, I’ve led R\&D strategy and operations in organizations ranging from early-stage startups to large global pharma, including Takeda, ImmunoGen, Novartis, and Biogen. I’ve had the privilege of building high-performing teams, guiding complex portfolios, and contributing to therapies that make a real difference for patients. Today, I enjoy advising innovative biotech companies and VCs as they shape the next generation of cancer treatments.

Ken Arnold is an accomplished medical device executive recognized for leading breakthrough innovations in laser technology and transforming companies through strategic vision and hands-on leadership. As CEO and Co-founder of Precise Light Surgical, he raised $17 million and guided the company from concept to commercialization with a novel tissue-sparing microsurgical platform. His earlier roles at Laserscope and Iridex underscore a consistent track record of scaling innovation into clinical and commercial success, including driving a $715 million acquisition and spearheading next-generation glaucoma treatments. With deep technical expertise, strong investor and clinical relationships, and a relentless focus on patient impact, Ken has built a career defined by precision, performance, and purpose.

After 25+ years working at the intersection of science and strategy in cell and gene therapy, I’m excited to share a comprehensive look into my professional journey—from hands-on scientific innovation to leadership across CDMOs, biotech, and academic institutions. My passion lies in building high-impact teams, developing therapies that matter, and bridging ideas to execution. Here is my biography.

Excited to share my professional executive biography! With over 20 years of experience in biotech program management, drug development, and regulatory strategy, I have had the privilege of leading cross-functional teams, guiding early-stage startups, and ensuring successful clinical execution. If you're looking for strategic leadership, operational excellence, and industry expertise, I’d love to connect and explore opportunities to collaborate.

Michael Ekstut is a seasoned business leader with over 30 years of experience in the life sciences industry, specializing in drug discovery, development, and regulatory strategy. He has held senior leadership roles at industry-leading companies, including Certara, where he guided the company’s commercial and product strategy in the regulatory and access sector. Michael is known for his strategic vision and ability to drive innovation, optimizing clinical development programs and supporting biopharma companies in navigating complex regulatory landscapes. His deep expertise in business consulting, technology, and operational management has enabled him to successfully advise executives and investors across pharmaceuticals, biotechnology, and medical devices. Currently serving as a Senior Advisor at InSilicoTrials, Michael continues to leverage his vast experience to help organizations maximize the impact of their clinical development programs and investments.

I’m thrilled to share my updated executive biography, highlighting my journey and experiences in the biotech and pharma industries. With over 30 years of experience, I’ve had the privilege of leading clinical operations, managing complex programs, and working with exceptional teams to drive advancements in clinical research. My recent role as Senior Director of Clinical Operations at uniQure allowed me to deepen my expertise in clinical development, cross-functional team leadership, and strategic program management. I’m passionate about leveraging this experience to contribute to innovative projects and impactful organizations. Thank you for taking the time to read about my professional journey. I look forward to connecting and exploring new opportunities where I can bring my skills and dedication to make a difference.